Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CMC Biologics
CMC Biologics
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
CMC Biologics to manufacture bispecific antibodies for F-star
Supporting F-star’s strong pipeline development in immuno-oncology
Manufacturing
CMC Biologics and IDT Biologika collaborate to manufacture antibody drug conjugates
Alliance will provide an efficient end-to-end solution for the development and manufacture of ADCs
Research & Development
CMC Biologics and PATH MVI to develop monoclonal antibodies to treat malaria
Manufacture of monoclonal antibodies to the malaria parasite scheduled for CMC’s Berkeley, US, facility
Manufacturing
CMC Biologics expands GMP manufacturing capacity in the US
Bioreactor 6Pack facility provides flexible solutions for Phase III and commercial production
Manufacturing
CMC Biologics adds capacity to GMP manufacturing facility in Denmark
Bioreactor 6Pack facility design provides flexible solutions for Phase III and commercial production
Manufacturing
CMC Biologics makes two appointments
Mark Sawicki and Patricio Massera join the CRO
Manufacturing
CMC Biologics and Inspiration agree supply of IB1001
For the treatment and prevention of bleeding in haemophilia B patients
Subscribe now